Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-099 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA) invites applications specific to infrastructure that will support, under a single cooperative agreement (U24), phenotypic data harmonization on subjects with Alzheimer's Disease Sequencing Project (ADSP) genetic and genomic data. These data will become a long-lived legacy data set that will be perpetually curated. The FOA will fund a single vanguard network of researchers with expertise in genetics, epidemiology, and clinical specialties who will work with the ADSP and with study cohort leads on data harmoni...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cance...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Notice of Change in Expiration Date of PAR-17-338 "Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases andDisorders (U01-Clinical Trials Not Allowed)"
Notice NOT-HL-19-474 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding
Digital, Limited Interaction Trials and Epidemiology (D-LITE): Targeting HIV Incidence in the United States (U01 Clinical Trial Required)
Funding Opportunity RFA-AI-19-067 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to conduct large-scale digital clinical trials to test whether digitally-delivered HIV prevention interventions can reduce HIV incidence among U.S. men who have sex with men (MSM) and/or transgender women and men. The major goal is to support investigators who will use innovative electronic methods to recruit and retain large samples of persons at high risk of HIV infections, conduct digitally-delivered interventions that promote HIV risk reduction and pre-e...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics
Notice NOT-DA-20-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 2, 2020 Category: Research Source Type: funding
Data are Available on NIH Funding Plans
The NIH-Wide Strategic Plan
for Fiscal Years (FYs 2016-2020)
laid the groundwork for discussing data on our funding strategies—see page 28
for example data on R01 applications across peer review percentiles in FY 2014.
The 21st Century Cures Act recognized the value of reporting such information.
Building on what we have blogged on before (see here, here, here, and here), let’s talk more about how we make
funding decisions and show some data as well.
Funding
decisions rely heavily on peer review scores, but there is more to the story. NIH
Institutes and Centers (ICs) weigh those scores together with ensuring their
...
Source: NIH Extramural Nexus - December 23, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike NIH Data Book NIH funding plans Source Type: funding
Learning from the Transfer of HIV Interventions from Low- and Middle-Income Countries (LMICs) to the United States: Informing the Plan for America to End the HIV Epidemic
Notice NOT-TW-19-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2019 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-20-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-20-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Well-suited applications must offer the potential...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-20-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-20-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2019 Category: Research Source Type: funding
Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National Ending the HIV Epidemic Goals (R01 and R34 Clinical Trial Optional)
Grants to support pilot, feasibility, implementation, or definitive studies on implementation approaches to enhance screening and treatment of substance use or mental health disorders in the HRSA Ryan White HIV/AIDS Program. Research sites should be located within the national End the Epidemic plan, including the top 48 counties; Washington, DC; San Juan, Puerto Rico; and the 7 states with a disproportionate occurrence of HIV in rural areas. Geographic coverage: Nationwide -- National Institute of Mental Health, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services (S...
Source: Funding opportunities via the Rural Health Information Hub - December 2, 2019 Category: American Health Source Type: funding
